Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 78 | 0 | 30 | 0 | €832.50 | €895.00 | 7.508% |
| AbbVie Inc. | 43 | 0 | 22 | 0 | €153.06 | €176.30 | 15.184% |
| Regeneron Pharmaceuticals Inc. | 48 | 1 | 12 | 0 | €946.40 | €1,034.6 | 9.323% |
| Sanofi S.A. | 14 | 0 | 11 | 0 | €91.00 | €100.00 | 9.890% |
| Alnylam Pharmace. | 47 | 0 | 11 | 0 | €227.60 | €251.80 | 10.634% |
| Amgen Inc. | 33 | 0 | 9 | 0 | €285.90 | €304.82 | 6.617% |
| Johnson & Johnson | 42 | 1 | 9 | 0 | €135.30 | €179.00 | 32.299% |
| Vertex Pharmaceuticals Inc. | 55 | 2 | 8 | 0 | €436.60 | €436.84 | 0.054% |
| Biogen Inc. | 57 | 1 | 8 | 0 | €208.10 | €291.49 | 40.073% |
| Gilead Sciences Inc | 19 | 1 | 8 | 0 | €61.24 | €76.50 | 24.918% |
| Pfizer Inc. | 35 | 4 | 8 | 0 | €25.97 | €40.00 | 54.054% |